Rakesh Dixit's Email & Phone Number

💼 Past Experience

DABT left BIONAVIGEN, LLC in Spring of 2016 as President & CEO. There he was responsible for oversees the day-to-day operations of the company, from developing new products to managing the company's relationships with its stakeholders. He held this position for two years.Prior to this appointment, DABT was the Ex-Vice President, R & D, Global Head, Biologics Safety Assessment at MedImmune. He held this position from December of 2014 through March of 2016. During his time at MedImmune, DABT developed and led clinical trials for several biologic products, responsible for the safety and efficacy of these products. In addition, he was also responsible for the day-to-day operations of the company's vaccine development programs, as well as its customer relationships. prior to joining MedImmune, DABT spent five years as an employee of AstraZeneca, most recently as an Ex-Vice President, R & D, Global Head, Product Development. At AstraZeneca, he was responsible for all aspects of product development, from preclinical to clinical testing. He was also responsible for developing and managing the company's overall safety and product development programs.DABT has a degree in medicine from the University of Mumbai, India.

🎓 Education

Rakesh DABT has a B.S. from Case Western Reserve University School of Medicine in 2002. He then proceeded to study at University of Lucknow in 2006, where he received his M.D. in 2010. Upon his completion of his MBA in 2016, he obtained his Doctorate in health sciences from the University of Lucknow. Rakesh has been a professional doctor since he obtained his Doctorate in Health Sciences. Rakesh DABT has worked as a doctor in different hospitals across Lucknow. He has also been a member of the Interdisciplinary Group of Physicians at the LucknowMedical University. He has been given awards by the faculty of LucknowMedical University for his outstanding work.

💡 Technical & Interpersonal Skills

Rakesh DABT has been with BIONAVIGEN sinceJanuary 2014 as President and CEO. He is responsible for all aspects of the company's R & D, product development, commercial strategy, and others areas of responsibility.Prior to joining BIONAVIGEN, Rakesh DABT worked as an EX-Vice President and Research and Development at MedImmune, a global faith-based healthcare company. At MedImmune, he was responsible for all aspects of the company's product development and commercial strategy. He was also responsible for the development and management of the company's R & D Department.Prior to joining MedImmune, Rakesh DABT was with AstraZeneca. He was an EX-Vice President and Research, Development and operations at AstraZeneca. He was also responsible for all aspects of the company's product development and commercial strategy. He was also responsible for the development and management of the company's R & D Department.